Clinical Trials
-
A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment of Acute HCV in HIV-1 Infected
Study Location: Baltimore
Eligibility: Men and women > 18 years, HIV+ and currently on stable antiretroviral (ARV) medications or on for at least 8 weeks and be...
Enrollment:
A5322: Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of
Study Location: Baltimore
Eligibility: Participants actively followed in the ALLRT (A5001) at the time of enrollment into A5322 or completed follow-up in ALLRT (A5001)...
Enrollment:
A5324: A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral
Study Location: Baltimore
Eligibility: Men and women > 18 years old who have HIV-associated neurocognitive disorder (HAND) as defined by the Frascati...
Enrollment:
A5320: Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
Study Location: Baltimore
Eligibility: Men and women ≥ 18 years old, HCV/HIV-1 coinfected who failed HCV therapy any time after HCV/DAA treatment discontinuation...
Enrollment:
A5314: Effect of LDMTX on Inflammation in HIV-infected Individuals
Study Location: Baltimore
Eligibility: HIV-infected men and women ≥40 years old, who have been virologically suppressed on continuous antiretroviral therapy for at...
Enrollment: Closed
A5225: Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated
Study Location: India
Eligibility: HIV-infected males and females ≥16 years of age presenting with their first episode of CM. Participants may not have received...
Enrollment:
A5273: Multicenter Study of Options for Second-Line Effective Combination Therapy (SELECT)
Study Location: India
Eligibility: Human immunodeficiency virus (HIV)-1 infected adults (age ≥18 years) who have confirmed virologic failure on an...
Enrollment: Closed
A5274: REMEMBER, Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment
Study Location: India
Eligibility: Participating sites must have a regional TB incidence (i.e., the TB incidence within the site’s expected catchment area)...
Enrollment:
A5282: A Randomized, Phase II Trial to Compare an HPV Test-and-Treat Strategy to a Cytology-Based
Study Location: India
Eligibility: HIV-infected women 18 years of age or older. Eligible participants should have no history of major cervical procedures or...
Enrollment: